STERIS plc (STE) Financial Statements
Historical financial data — 28 statements covering FY2019–FY2026
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring t...
STERIS plc's revenue increased 8.7% year over year, from $5.46B to $5.94B.
Net income increased 27.3% over the same period, from $614.6M to $782.3M.
Over the 7-year period from FY2019 to FY2026, revenue grew by 113% in total.
Total debt decreased by 5.5% to $1.93B.
The debt-to-equity ratio stands at 0.27, indicating a conservative leverage profile.
Operating cash flow grew 16.8% to $1.34B.
STERIS plc maintains a healthy net profit margin of 13.2%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2024 | $2.63B+104.5% | $238.9M | $1.17B | $374.7M | $427.2M | $11.28B | $3.44B | $6.18B |
| Q3 FY2024 | $4.02B+53.1% | $379.6M | $1.77B | $590.9M | $718.5M | $11.44B | $3.31B | $6.42B |
| Q1 FY2025 | $1.28B-68.2% | $145.4M | $572.4M | $185.5M | $303.7M | $10.11B | $2.32B | $6.35B |
| Q2 FY2025 | $2.61B+103.9% | $295.4M | $1.15B | $405.2M | $554.5M | $10.24B | $2.24B | $6.59B |
| Q3 FY2025 | $3.98B+52.5% | $469.0M | $1.76B | $650.5M | $887.3M | $10.01B | $2.16B | $6.42B |
| Q1 FY2026 | $1.39B-65.0% | $177.4M | $628.0M | $246.0M | $420.0M | $10.40B | $1.90B | $6.96B |
| Q2 FY2026 | $2.85B+105.0% | $369.2M | $1.27B | $511.8M | $707.8M | $10.41B | $1.90B | $7.01B |
| Q3 FY2026 | $4.35B+52.5% | $562.1M | $1.93B | $785.0M | $1.01B | $10.59B | $1.90B | $7.15B |
Balance Sheet Summary (Latest Period)
Total Assets
$10.74B
Total Liabilities
$3.54B
Total Equity
$7.18B
Cash & Equivalents
$439.6M
Total Debt
$1.93B
Current Assets
$2.39B
Current Liabilities
$1.15B
Retained Earnings
$3.02B